We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$169B
AUM Growth
+$5.04B
Cap. Flow
+$3.65B
Cap. Flow %
2.15%
Top 10 Hldgs %
14.9%
Holding
3,259
New
48
Increased
2,253
Reduced
524
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 17.19%
2 Financials 14.38%
3 Healthcare 12.23%
4 Industrials 10.47%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YARW
3076
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$145K ﹤0.01%
9
-6
-40% -$96.8K
TPST icon
3077
Tempest Therapeutics
TPST
$13.9M
$139K ﹤0.01%
100
KDNY
3078
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$139K ﹤0.01%
26,080
-35,136
-57% -$233K
SND icon
3079
Smart Sand
SND
$184M
$137K ﹤0.01%
48,150
-78,011
-62% -$195K
BBCP icon
3080
Concrete Pumping Holdings
BBCP
$498M
$136K ﹤0.01%
34,136
+11,133
+48% +$47K
MRSN
3081
DELISTED
Mersana Therapeutics
MRSN
$135K ﹤0.01%
3,402
MJCO
3082
DELISTED
Majesco
MJCO
$133K ﹤0.01%
15,678
ICD
3083
DELISTED
Independence Contract Drilling, Inc.
ICD
$130K ﹤0.01%
5,393
CBUS icon
3084
Cibus
CBUS
$144M
$124K ﹤0.01%
437
CKPT
3085
DELISTED
Checkpoint Therapeutics
CKPT
$120K ﹤0.01%
4,797
SOLY
3086
DELISTED
Soliton, Inc.
SOLY
$119K ﹤0.01%
+11,097
New +$143K
KZR
3087
DELISTED
Kezar Life Sciences
KZR
$115K ﹤0.01%
3,506
IMDX
3088
Insight Molecular Diagnostics
IMDX
$148M
$114K ﹤0.01%
2,704
-193
-7% -$7.58K
RTW
3089
DELISTED
RTW Retailwinds, Inc.
RTW
$114K ﹤0.01%
82,711
-31,470
-28% -$49.2K
LQDA icon
3090
Liquidia Corp
LQDA
$7.6B
$110K ﹤0.01%
30,682
PTE
3091
DELISTED
PolarityTE, Inc. Common Stock
PTE
$110K ﹤0.01%
1,358
SER icon
3092
Serina Therapeutics
SER
$31.3M
$108K ﹤0.01%
1,560
LKSD
3093
DELISTED
LSC Communications, Inc.
LKSD
$107K ﹤0.01%
77,272
-96,989
-56% -$180K
XCUR icon
3094
Exicure
XCUR
$10.1M
$98K ﹤0.01%
+258
New +$98.7K
PHUN icon
3095
Phunware
PHUN
$43.3M
$97K ﹤0.01%
+1,346
New +$118K
VBIV
3096
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$95K ﹤0.01%
6,695
ACRS icon
3097
Aclaris Therapeutics
ACRS
$722M
$92K ﹤0.01%
84,702
-121,887
-59% -$173K
BTAI icon
3098
BioXcel Therapeutics
BTAI
$24.7M
$89K ﹤0.01%
784
VNRX icon
3099
VolitionRx Ltd
VNRX
$8.86M
$87K ﹤0.01%
769
CHAP
3100
DELISTED
Chaparral Energy, Inc.
CHAP
$87K ﹤0.01%
64,581

Similar funds

Charles Schwab's Q3 2019 Portfolio in Review

As of Q3 2019, Charles Schwab held 3,259 positions worth $169B, up 3.1% from $164B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4%. Charles Schwab opened 48 new positions and exited 81, leaving the 3,259-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q3 2019 buy was Blackstone: 1,331,026 shares worth $65M.
  • Charles Schwab added most to Fidelity National Information Services in Q3 2019, an estimated $167M increase.
  • Charles Schwab's biggest Q3 2019 reduction was Amcor, cutting an estimated $61.6M.
  • Charles Schwab fully exited Anadarko Petroleum in Q3 2019, selling an estimated $179M.
  • Charles Schwab's ten largest holdings make up 15% of its $169B portfolio in Q3 2019.
  • Charles Schwab opened 48 new positions and closed 81 in Q3 2019.
  • Charles Schwab's portfolio value rose 3.1% quarter-over-quarter to $169B.

Based on Charles Schwab's 13F filing for Q3 2019, filed 8 Nov 2019.